Loading clinical trials...
Loading clinical trials...
A Phase II Study of Gemcitabine Plus Oxaliplatin for Patients With Advanced Stage IIIB or IV Non-Small Cell Lung Cancer
Conditions
Interventions
Oxaliplatin
Gemcitabine
Locations
1
South Korea
National Cancer Center, Korea
Goyang-si, Gyeonggi-dog, South Korea
Start Date
January 1, 2006
Primary Completion Date
May 1, 2010
Completion Date
May 1, 2011
Last Updated
October 25, 2010
NCT06498635
NCT06305754
NCT05198830
NCT05692635
NCT06066138
NCT07486219
Lead Sponsor
National Cancer Center, Korea
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions